arrow
Back
P

Peter K. Kaiser

cleveland clinic foundation

82H-index
772Paper Count
4.0WCitation Count
Published Papers 180
Publication Date
Outcomes and Complications of Pars Plana Vitrectomy for Non-clearing Vitreous Hemorrhage without Tractional Elements
err2026-01-29
err0
PREAI
errJustin C. Muste; Matthew J. Schulgit; Scott Perkins; Matthew Russell; Saam Mojtahed; Alex Yuan; Jonathan E. Sears; Phoebe Lin; Aleksandra Rachitskaya; Sunil K. Srivastava; Katherine E. Talcott; Peter Kaiser; Justis P. Ehlers; Danny A. Mammo; Rishi P. Singh; Daniel F. Martin; Andrew P. Schachat; Sumit Sharma
errShare
errSave
Swept-Source OCT and OCTA B-Scan Analysis of Inflammatory Retinal Vascular Changes: Quantitative and Qualitative Assessment
err2026-01-14
err0
PREAI
errYuka Mizuno; Sunil K. Srivastava; Sandeep Singh; Jon Whitney; Kimberly Baynes; Peter K. Kaiser; Careen Y. Lowder; Phoebe Lin; Danny A. Mammo; Justis P. Ehlers; Sumit Sharma
errShare
errSave
Real-World Functional and Anatomic Outcomes With Aflibercept 8.0 mg in Patients With Diabetic Macular Edema
err2026-01-01
err1
PREAI
errBarbosa, Gabriel Castilho S.; Bala, Suraj; Mohan, Nitesh; Srivastava, Sunil K.; Kaiser, Peter K.; Sastry, Ananth; Babiuch, Amy S.; Sears, Jonathan; Talcott, Katherine E.; Yuan, Alex; Rachitskaya, Aleksandra; Ehlers, Justis P.; Schachat, Andrew P.; Lin, Phoebe; Sharma, Sumit; Mammo, Danny A.
errShare
errSave
TALON phase IIIb study: 64 week results of brolucizumab versus aflibercept using treat-and-extend for neovascular age-related macular degeneration
errEye
IF3.2
err2025-12-18
err0
errOAAI
errCarl Regillo; Peter K. Kaiser; Peter J. Kertes; Mark Gillies; Tina Maio-Twofoot; David Lawrence; Frank G. Holz
errShare
errSave
OphthoEvidence report: Baseline structural optical coherence tomography biomarkers predictive of visual acuity following epiretinal membrane surgery-A systematic review and meta-analysis protocol
err2025-12-16
err0
PREAI
errChu, Xiajing; Lima, Joao Pedro; Zeraatkar, Dena; Ma, Jinhui; Prasad, Femin; Srinivasan, Sangeetha; Sivaprasad, Sobha; Sandinha, Teresa; Kaiser, Peter; Steel, David H.; Wong, Tien Yin; Wykoff, Charles C.; Chaudhary, Varun
errShare
errSave
Avacincaptad pegol for geographic atrophy secondary to age-related macular degeneration: 2-year efficacy and safety results from the GATHER2 phase 3 trial
err2025-12-15
err0
errOAAI
errArshad M. Khanani; Carl J. Danzig; Jeffrey S. Heier; Glenn J. Jaffe; Peter K. Kaiser; David R. Lally; Sunil S. Patel; Lejla Vajzovic; Christina Y. Weng; Hersh Patel; Julie Clark; Dhaval Desai; Don Luo; Erin Henry; Frank G. Holz
errShare
errSave
Risk Factors and Systemic Outcomes in Patients with Retinal Artery Occlusion
err2025-11-19
err0
PREAI
errAusten N. Knapp; Matthew J. Schulgit; Sumit Sharma; Abel Hamdan; Alex Yuan; Amy Babiuch; Justis P. Ehlers; Peter K. Kaiser; Aleksandra Rachitskaya; Jonathan Sears; Rishi P. Singh; Katherine Talcott; Daniel F. Martin; Kimberly Baynes; Andrew P. Schachat; Sunil K. Srivastava
errShare
errSave
Visual outcomes associated with optical coherence tomography biomarkers in diabetic macular edema: A systematic review
err2025-09-17
err0
PREAI
errKeean Nanji; Amin Hatamnejad; Justin Grad; Abdullah El-Sayes; Andrew Mihalache; Mohamed Gemae; Ryan Huang; Mark Phillips; Dena Zeraatkar; Rishi Singh; Marion R Munk; SriniVas R. Sadda; David Sarraf; Peter Kaiser; Robyn Guymer; Sobha Sivaprasad; Samantha Fraser-Bell; Yih Chung Tham; Sunir J. Garg; Tien Yin Wong; Charles C. Wykoff; Varun Chaudhary
errShare
errSave
Semi-Automated Analysis of Anterior Chamber Inflammation by Spectral-Domain Optical Coherence Tomography in Cataract Surgery Patients
err2025-09-03
err0
PREAI
errNaveen Karthik; Sunil K. Srivastava; Richard Gans; Kimberly Baynes; Emily Fisher; Cindy Chen; Peter K. Kaiser; Arthi Venkat; Careen Y. Lowder; Sumit Sharma
errShare
errSave
Baseline Optical Coherence Tomography Biomarkers Associated with Visual Acuity in Diabetic Macular Edema: A Systematic Review and Meta-Analysis
err2025-08-11
err0
errOAAI
errKeean Nanji; Justin Grad; Amin Hatamnejad; Abdullah El-Sayes; Andrew Mihalache; Mohamed Gemae; Ryan Huang; Mark Phillips; Peter K. Kaiser; Marion R. Munk; Sunir J. Garg; David Sarraf; SriniVas R. Sadda; Samantha Fraser-Bell; Dena Zeraatkar; Jinhui Ma; Enrico Borrelli; David H. Steel; Sobha Sivaprasad; Charles C. Wykoff; Varun Chaudhary
errShare
errSave
TALON Phase IIIb Study: 32-Week Primary Results of Brolucizumab Using Treat and Extend for Neovascular Age-Related Macular Degeneration
err2025-06-02
err0
PREAI
errCarl Regillo; Peter K. Kaiser; Peter J. Kertes; Mark Gillies; Tina Maio-Twofoot; Divya D’Souza; Siegbert Guenther; David Lawrence; Frank G. Holz
errShare
errSave
Determinants of Four-Year Visual Acuity Loss in Geographic Atrophy
err2025-02-05
err0
PREAI
errLiangbo Linus Shen; Peter K. Kaiser; Jeremy Liu; Jay M. Stewart; Michael Heyang; Tiarnan D.L. Keenan; Janet S. Sunness; Philip J. Rosenfeld; Emily Y. Chew; Lucian V. Del Priore
errShare
errSave
ReCLAIM-2: A Randomized Phase II Clinical Trial Evaluating Elamipretide in Age-related Macular Degeneration, Geographic Atrophy Growth, Visual Function, and Ellipsoid Zone Preservation
err2025-01-01
err3
errOAAI
errEhlers, Justis P.; Hu, Allen; Boyer, David; Cousins, Scott W.; Waheed, Nadia K.; Rosenfeld, Philip J.; Brown, David; Kaiser, Peter K.; Abbruscato, Anthony; Gao, Gui; Heier, Jeffrey
errShare
errSave
International Classification System for Ocular Complications of Anti-VEGF Agents in Clinical Trials
err2024-12-01
err0
errOAAI
errPopovic, Marko M.; Balas, Michael; Sadda, SriniVas R.; Sarraf, David; Huang, Ryan; Bakri, Sophie J.; Berrocal, Audina; Chang, Andrew; Cheung, Chui Ming Gemmy; Garg, Sunir; Hillier, Roxane J.; Holz, Frank G.; Johnson, Mark W.; Kaiser, Peter K.; Kertes, Peter J.; Lai, Timothy Y. Y.; Noble, Jason; Park, Susanna S.; Paulus, Yannis M.; Querques, Giuseppe; Rachitskaya, Aleksandra; Ruamviboonsuk, Paisan; Saidkasimova, Shohista; Sandinha, Maria Teresa; Steel, David H.; Terasaki, Hiroko; Weng, Christina Y.; Williams, Basil K.; Wu, Lihteh; Muni, Rajeev H.
errShare
errSave
Visual Loss in Geographic Atrophy Learnings from the Lampalizumab Trials
err2024-11-01
err0
errOAAI
errAnegondi, Neha; Steffen, Verena; Sadda, Srinivas R.; Schmitz-Valckenberg, Steffen; Tufail, Adnan; Csaky, Karl; Lad, Eleonora M.; Kaiser, Peter K.; Ferrara, Daniela
errShare
errSave
Bispecific VEGF-A and Angiopoietin-2 Antagonist RO-101 Preclinical Efficacy in Model of Neovascular Eye Disease
err2024-07-01
err0
errOAAI
errXu, Li; Prentice, Jessi R.; Velez-Montoya, Raul; Sinha, Alina; Barakat, Mark R.; Gupta, Ashwin; Lowenthal, Robert; Khanani, Arshad M.; Kaiser, Peter K.; Heier, Jeffrey S.; Jones, Anthony; Morgenstern, Joshua L.; Caldwell, Anne Strong; Mueller, Niklaus; Quiroz-Mercado, Hugo; Huvard, Michael; Olson, Jeffrey L.; Bhatt, Ramesh; Bhandan, Ramanath
errShare
errSave
Biosimilars of anti-vascular endothelial growth factor for ophthalmic diseases: A review
err2024-07-01
err3
errOAAI
errBressler, Neil M.; Kaiser, Peter K.; Do, Diana, V; Nguyen, Quan Dong; Park, Kyu Hyung; Woo, Se Joon; Sagong, Min; Bradvica, Mario; Kim, Mercy Yeeun; Kim, Seungkee; Sadda, SriniVas R.
errShare
errSave
The effect of complement C3 or C5 inhibition on geographic atrophy secondary to age-related macular degeneration: A living systematic review and meta-analysis
err2024-05-01
err6
PREAI
errGarg, Anubhav; Nanji, Keean; Tai, Felicia; Phillips, Mark; Zeraatkar, Dena; Garg, Sunir J.; Sadda, SriniVas R.; Kaiser, Peter K.; Guymer, Robyn H.; Sivaprasad, Sobha; Wykoff, Charles C.; Chaudhary, Varun
errShare
errSave
Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial
errLANCET
IF88.5
err2023-10-01
err84
errOAAI
errKhanani, Arshad M.; Patel, Sunil S.; Staurenghi, Giovanni; Tadayoni, Ramin; Danzig, Carl J.; Eichenbaum, David A.; Hsu, Jason; Wykoff, Charles C.; Heier, Jeffrey S.; Lally, David R.; Mones, Jordi; Nielsen, Jared S.; Sheth, Veeral S.; Kaiser, Peter K.; Clark, Julie; Zhu, Liansheng; Patel, Hersh; Tang, Justin; Desai, Dhaval; Jaffe, Glenn J.
errShare
errSave
Oral APX3330 Reduces the DRSS Worsening after 24-weeks of Daily Treatment-Efficacy and Safety Results of the ZETA-1 Phase 2 Trial in Diabetic Retinopathy
err2023-06-20
err1
PREAI
errGonzalez, Victor H.; Brigell, Mitchell G.; Su, Daniel; Patel, Ronil; Withers, Barbara; Kelley, Mark; Haddad, Louis; Sooch, Mina; Pepose, Jay S.; Kaiser, Peter K.; Boyer, David S.
errShare
errSave